Factors associated with attrition from a randomized controlled trial of meaning-centered group psychotherapy for patients with advanced cancer

Psycho-Oncology

Volumn 21, Issue 11, 2012, Pages 1195-1204

  Applebaum, Allison J ^a   Lichtenthal, Wendy G ^a   Pessin, Hayley A ^a   Radomski, Julia N ^a   Simay Gokbayrak N ^b   Katz, Aviva M ^c   Rosenfeld, Barry ^d   Breitbart, William ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c SUFFOLK UNIVERSITY   (United States)

^d FORDHAM UNIVERSITY   (United States)

Author keywords

attrition; cancer; meaning; palliative care; psychotherapy

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER PALLIATIVE THERAPY; CONTROLLED STUDY; FEMALE; FINANCIAL MANAGEMENT; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEANING CENTERED GROUP PSYCHOTHERAPY; PATIENT PARTICIPATION; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RELIGION; SOCIAL PSYCHOLOGY; SOLID TUMOR; SUPPORTIVE GROUP PSYCHOTHERAPY; TRAVEL; WELLBEING;

ATTRITION; CANCER; MEANING; PALLIATIVE CARE; PSYCHOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; NEW YORK CITY; PALLIATIVE CARE; PATIENT COMPLIANCE; PATIENT DROPOUTS; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; SELF-HELP GROUPS; SEVERITY OF ILLNESS INDEX; TERMINAL CARE; TERMINALLY ILL; TREATMENT OUTCOME;

EID: 84868579260     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.2013     Document Type: Article

References (85)

1. Jordhoy MS, Kaasa S, Fayers P, et al., Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial. Palliat Med 1999; 13 (4): 299-310.
2. Ewing G, Rogers M, Barclay S, et al., Recruiting patients into a primary care based study of palliative care: why is it so difficult? Palliat Med 2004; 18 (5): 452-459.
3. Sherman DW, McSherry CB, Parkas V, et al., Recruitment and retention in a longitudinal palliative care study. Appl Nurs Res 2005; 18 (3): 167-177.
4. Steinhauser KE, Clipp EC, Hays JC, et al., Identifying, recruiting, and retaining seriously-ill patients and their caregivers in longitudinal research. Palliat Med 2006; 20 (8): 745-754.
5. Deeg DJ, van Tilburg T, Smit JH, et al., Attrition in the longitudinal aging study Amsterdam. The effect of differential inclusion in side studies. J Clin Epidemiol 2002; 55 (4): 319-328.
6. Leon AC, Mallinckrodt CH, Chuang-Stein C, et al., Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biol Psychiatry 2006; 59 (11): 1001-1005.
7. Siddiqi AE, Sikorskii A, Given CW, et al., Early participant attrition from clinical trials: role of trial design and logistics. Clin Trials 2008; 5 (4): 328-335.
8. Barrett MS, Chua WJ, Crits-Christoph P, et al., Early withdrawal from mental health treatment: implications for psychotherapy practice. Psychotherapy 2008; 45 (2): 247-267.
9. Davis MJ, Addis ME,. Predictors of attrition from behavioral medicine treatments. Ann Behav Med 1999; 21 (4): 339-349.
10. Grilo CM, Money R, Barlow DH, et al., Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder. Compr Psychiatry 1998; 39 (6): 323-332.
11. Hofmann SG, Suvak M,. Treatment attrition during group therapy for social phobia. J Anxiety Disord 2006; 20 (7): 961-972.
12. Issakidis C, Andrews G,. Pretreatment attrition and dropout in an outpatient clinic for anxiety disorders. Acta Psychiatr Scand 2004; 109 (6): 426-433.
13. Last CG, Thase ME, Hersen M, et al,. Patterns of attrition for psychosocial and pharmacologic treatments of depression. J Clin Psychiatry 1985; 46 (9): 361-366.
14. Monroe SM, Roberts JE, Kupfer DJ, et al,. Life stress and treatment course of recurrent depression: II. Postrecovery associations with attrition, symptom course, and recurrence over 3 years. J Abnorm Psychol 1996; 105 (3): 313-328.
15. Oei TP, Kazmierczak T,. Factors associated with dropout in a group cognitive behaviour therapy for mood disorders. Behav Res Ther 1997; 35 (11): 1025-1030.
16. Pena JM, Franklin RR, Rice JC, et al., A two-rate hypothesis for patterns of retention in psychosocial treatments of cocaine dependence: findings from a study of African-American men and a review of the published data. Am J Addict 1999; 8 (4): 319-331.
17. Self R, Oates P, Pinnock-Hamilton T, et al., The relationship between social deprivation an unilateral termination (attrition) from psychotherapy at various stages in the heath care pathway. Psychol Psychother 2005; 78: 95-111.
18. Shaw WS, Cronan TA, Christie MD,. Predictors of attrition in health intervention research among older subjects with osteoarthritis. Health Psychol 1994; 13 (5): 421-431.
19. Wierzbicki M, Pekarik G,. A meta-analysis of psychotherapy dropout. Prof Psychol Res Pr 1993; 24: 190-195.
20. Given C, Given B, Rahbar M, et al., Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol 2004; 22 (3): 507-516.
21. Manne S, Ostroff JS, Winkel G,. Social-cognitive processes as moderators of a couple-focused group intervention for women with early stage breast cancer. Health Psychol 2007; 26 (6): 735-744.
22. Moorey S, Cort E, Kapari M, et al., A cluster randomized controlled trial of cognitive behaviour therapy for common mental disorders in patients with advanced cancer. Psychol Med 2009; 39 (5): 713-723.
23. Centorrino F, Hernan MA, Drago-Ferrante G, et al., Factors associated with noncompliance with psychiatric outpatient visits. Psychiatr Serv 2001; 52 (3): 378-380.
24. Davis L, Evans S, Fishman B, et al., Predictors of attrition in HIV-positive subjects with peripheral neuropathic pain. AIDS Care 2004; 16 (3): 395-402.
25. DiMatteo MR, Giordani PJ, Lepper HS, et al., Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40 (9): 794-811.
26. Gonzalez JS, Peyrot M, McCarl LA, et al,. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 2008; 31 (12): 2398-2403.
27. Kissane D,. Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology 2009; 18 (1): 1-5.
28. Rynn M, Russell J, Erickson J, et al., Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. Depress Anxiety 2008; 25 (3): 182-189.
29. Van der Veen WJ, Van der Meer K, Penninx BW,. Screening for depression and anxiety: correlates of non-response and cohort attrition in the Netherlands study of depression and anxiety (NESDA). I. Int Clin Psychopharmacol 2009; 18 (4): 229-239.
30. Warden D, Trivedi MH, Wisniewski SR,. Predictors of attrition during initial (citalopram) treatment of depression: a STARD report. Am J Psychiatry 2003; 160: 533-540.
31. Garland SN, Carlson LE, Cook S, et al., A non-randomized comparison of mindfulness-based stress reduction and healing arts programs for facilitating post-traumatic growth and spirituality in cancer outpatients. Support Care Cancer 2007; 15 (8): 949-961.
32. Bebbington PE, Marsden L, Brewin CR,. The need for psychiatric treatment in the general population: the Camberwell needs for care survey. Psychol Med 1997; 27 (4): 821-834.
33. Bjordal K, Ahlner-Elmqvist M, Hammerlid E, et al., A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope 2001; 111 (8): 1440-1452.
34. Bradley NM, Chow E, Tsao MN, et al., Reasons for poor accrual in palliative radiation therapy research studies. Support Cancer Ther 2006; 3 (2): 110-119.
35. Dean RA, McClement SE,. Palliative care research: methodological and ethical challenges. Int J Palliat Nurs 2002; 8 (8): 376-380.
36. Dobratz MC,. Issues and dilemmas in conducting research with vulnerable home hospice participants. J Nurs Scholarsh 2003; 35 (4): 371-376.
37. Ling J, Rees E, Hardy J,. What influences participation in clinical trials in palliative care in a cancer centre?. Eur J Cancer 2000; 36 (5): 621-626.
38. Mihelic AH, Crimmins EM,. Loss to folow-up in a sample of Americans 70 years of age and older: The LSOA 1984-1990. J Gerontol B Psychol Sci Soc Sci 1997; 52 (1): S37-S48.
39. Clough-Gorr KM, Fink AK, Silliman RA,. Challenges associated with longitudinal survivorship research: attrition and a novel approach of reenrollment in a 6-year follow-up study of older breast cancer survivors. J Cancer Surviv 2008; 2 (2): 95-103.
40. Hazrah P, Parshad R, Dhir M, et al., Factors associated with attrition in patients with breast cancer: a retrospective study. Natl Med J India 2007; 20 (5): 230-233.
41. Arnow BA, Blasey C, Manber R, et al., Dropouts versus completers among chronically depressed outpatients. J Affect Disord 2007; 97 (1-3): 197-202.
42. Baquet CR, Commiskey P, Daniel Mullins C, et al., Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev 2006; 30 (1): 24-33.
43. Bastiaens L,. Response to antidepressant treatment in a community mental health center. Community Ment Health J 2004; 40 (6): 561-567.
44. Bender BG, Ellison MC, Gleason M, et al., Minimizing attrition in a long-term clinical trial of pediatric asthma. Ann Allergy Asthma Immunol 2003; 91 (2): 168-176.
45. Fair AM, Wujcik D, Lin JM, et al., Timing is everything: methodologic issues locating and recruiting medically underserved women for abnormal mammography followup research. Contemp ClinTrials 2008; 29 (4): 537-546.
46. Krishnan E, Murtagh K, Bruce B, et al., Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment Questionnaire. J Rheumatol 2004; 31 (7): 1320-1326.
47. Nantz E, Liu-Seifert H, Skljarevski V,. Predictors of premature discontinuation of treatment in multiple disease states. Patient Prefer Adherence 2009; 3: 31-43.
48. Neumark DE, Stommel M, Given CW, et al., Research design and subject characteristics predicting nonparticipation in a panel survey of older families with cancer. Nurs Res 2001; 50 (6): 363-368.
49. Warden D, Rush AJ, Carmody TJ, et al., Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention. J Psychiatr Pract 2009; 15 (2): 113-124.
50. Sikorskii A, Wyatt GK, Siddiqi AE, et al., Recruitment and early retention of women with advanced breast cancer in a complementary and alternative medicine trial. Evid Based Complement Alternat Med 2009.
51. Blumenthal DS, Sung J, Coates R, et al., Recruitment and retention of subjects for a longitudinal cancer prevention study in an inner-city black community. Health Serv Res 1995; 30 (1 Pt 2): 197-205.
52. Warden D, Rush AJ, Wisniewski SR, et al., Income and attrition in the treatment of depression: a STARD report. Depress Anxiety 2009; 26 (7): 622-633.
53. Bakker A, Spinhoven P, van Balkom AJ, et al., Cognitive therapy by allocation versus cognitive therapy by preference in the treatment of panic disorder. Psychother Psychosom 2000; 69 (5): 240-243.
54. Bakker A, et al., Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. J Clin Psychiatry 1999; 60 (12): 831-838.
55. Bedi N, Chilvers C, Churchill R, et al., Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry 2000; 177: 312-318.
56. Bower P, Byford S, Sibbald B, et al., Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness. BMJ 2000; 321 (7273): 1389-1392.
57. Chilvers C, Dewey M, Fielding K, et al., Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ 2001; 322 (7289): 772-775.
58. King M, Sibbald B, Ward E, et al., Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. Health Technol Assess 2000; 4 (19): 1-83.
59. Reddihough DS, King J, Coleman G, et al., Efficacy of programmes based on Conductive Education for young children with cerebral palsy. Dev Med Child Neurol 1998; 40 (11): 763-770.
60. Ward E, et al,. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: clinical effectiveness. BMJ 2000; 321 (7273): 1383-1388.
61. Kwan B, Dimidjian S, Rizvi S,. Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression. Behav Res Ther 2010; 48 (8): 799-804.
62. Group PCR,. Patients' preferences within randomized trials: systematic review and patient level meta-analysis. BMJ 2008; 337: a1864.
63. Pessin H, Galietta M, Nelson CJ, et al., Burden and benefit of psychosocial research at the end of life. J Palliat Med 2008; 11 (4): 627-632.
64. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67 (6): 361-370.
65. Beck AT, Weissman A, Lester D, et al., The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974; 42 (6): 861-865.
66. Beck AT, Ward CH, Mendelson M, et al., An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
67. Brady MJ, Peterman AH, Fitchett G, et al., A case for including spirituality in quality of life measurement in oncology. Psychooncology 1999; 8 (5): 417-428.
68. Peterman AH, Fitchett G, Brady MJ, et al., Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy-spiritual well-being scale (FACIT-Sp). Ann Behav Med 1996; 24 (1): 49-58.
69. Maltby J,. Religious orientation and Eysenck's personality dimensions: the use of the amended religious orientation scale to examine the relationship between religiosity, psychoticism, neuroticism, and extraversion. Pers Indiv Differ 1999; 26: 79-84.
70. Karnofsky DA, Burchenal JH,. The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of Chemotherapeutic Agents, MacLeod CM, (ed.), Columbia Univ Press, 1949; 196.
71. Schag CC, Heinrich RL, Ganz PA,. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 1984; 2 (3): 187-193.
72. Breitbart W,. Spirituality and meaning in supportive care: spirituality and meaning-centered group psychotherapy intervention in advanced cancer. Support Care Cancer 2000; 10: 272-278.
73. Breitbart W, Rosenfeld B, Gibson C, et al., Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial. Psychooncology 2010; 19 (1): 21-28.
74. Greenstein M, Breitbart W,. Cancer and the experience of meaning: a group psychotherapy program for people with cancer. Am J Psychother 2000; 54 (4): 486-500.
75. Frankl VF,. Man's Search for Meaning Massachusetts: Beacon Press, 1959.
76. Frankl VF,. The Will to Meaning: Foundations and Applications of Logotherapy, (expanded edn), Penguin Books: New York, 1969.
77. Cain EN, Kohorn EI, Quinlan DM, et al., Psychosocial benefits of a cancer support group. Cancer 1986; 57 (1): 183-189.
78. Payne DK, Lundberg JC, Brennan MF, et al., A psychosocial intervention for patients with soft tissue sarcoma. Psychooncology 1997; 6 (1): 65-71.
79. Savard J, Simard S, Giguere I, et al., Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat Support Care 2006; 4 (3): 219-237.
80. Allen SM, Shah AC, Nezu AM, et al., A problem-solving approach to stress reduction among younger women with breast carcinoma: a randomized controlled trial. Cancer 2002; 94 (12): 3089-3100.
81. Lengacher CA, Johnson-Mallard V, Post-White J, et al., Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology 2009; 18 (12): 1261-1272.
82. Campanini RF, Schoedl AF, Pupo MC, et al., Efficacy of interpersonal therapy-group format adapted to post-traumatic stress disorder: an open-label add-on trial. Depress Anxiety 2010; 27 (1): 72-77.
83. Swan J, Sorrell E, MacVicar B, et al., Coping with depression: an open study of the efficacy of a group psychoeducational intervention in chronic, treatment-refractory depression. J Affect Disord 2004; 82 (1): 125-129.
84. Stromgren AS, Sjogren P, Goldschmidt D, et al., A longitudinal study of palliative care: patient-evaluated outcome and impact of attrition. Cancer 2005; 103 (8): 1747-1755.
85. Horvath A, Greenberg L,. Development and validation of the Working Alliance Inventory. J Couns Psychol 1989; 36: 223-233.